Giovanna Polcaro

Via Salvador Allende 43
Baronissi, 84031, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Journal: Journal of medicinal chemistry

Published: February 23, 2026

Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.

Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand-Ir(III) Complex Conjugates.

Journal: Cancer communications (London, England)

Published: December 16, 2025

rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy.

rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy.

Journal: Journal for immunotherapy of cancer

Published: November 05, 2025

BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target.

BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target.

Journal: Current oncology reports

Published: October 19, 2025

Pathological complete response in a POLE-mutated non-small cell lung cancer patient treated with perioperative chemoimmunotherapy: a case report and review of the literature.

Pathological complete response in a POLE-mutated non-small cell lung cancer patient treated with perioperative chemoimmunotherapy: a case report and review of the literature.

Journal: MedScience

Published: September 27, 2025

Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma.

Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma.

Journal: Translational oncology

Published: February 14, 2025

Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors.

Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors.

Journal: Scientific reports

Published: January 25, 2025

Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy.

Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy.

Journal: Journal of personalized medicine

Published: May 20, 2024

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study.

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study.

Journal: Frontiers in immunology

Published: April 18, 2024

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC.

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC.

Journal: Molecular cancer

Published: November 03, 2023

Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series.

Prior Anti-Angiogenic TKI-Based Treatment as Potential Predisposing Factor to Nivolumab-Mediated Recurrent Thyroid Disorder Adverse Events in mRCC Patients: A Case Series.

Journal: Biomedicines

Published: October 02, 2023

Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review.

Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review.

Journal: Clinics and practice

Published: September 24, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026